A Bioequivalence Study to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety After Administration of IN-R00002 and IN-G00002 in Healthy Adult Volunteers
Latest Information Update: 18 Dec 2024
Price :
$35 *
At a glance
- Drugs IN-G00002 (Primary) ; IN-R00002 (Primary)
- Indications Atrial fibrillation
- Focus Pharmacokinetics
- Sponsors HK inno.N
- 18 Dec 2024 New trial record